Moderna stock surges 17% on coronavirus vaccine trial news - MarketWatch

New study shows ‘robust’ immune response to trial vaccine, Moderna says

Moderna stock surges 17% on coronavirus vaccine trial news - MarketWatch


SOURCE: MarketWatch

Click here to READ THE FULL STORY.